Lung screen uptake trial (LSUT): Randomized controlled clinical trial testing targeted invitation materials

American Journal of Respiratory and Critical Care Medicine

Volumn 201, Issue 8, 2020, Pages 965-975

  Quaife, Samantha L ^a   Ruparel, Mamta ^b   Dickson, Jennifer L ^b   Beeken, Rebecca J ^a,c   McEwen, Andy ^d   Baldwin, David R ^e   Bhowmik, Angshu ^f   Navani, Neal ^g   Sennett, Karen ^h   Duffy, Stephen W ⁱ   Wardle, Jane ^a   Waller, Jo ^a,j   Janes, Samuel M ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d National Centre for Smoking Cessation and Training   (United Kingdom)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^f HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^h Killick Health Centre   (United Kingdom)

ⁱ QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Behavioral sciences; Early detection of cancer; Lung neoplasms; Socioeconomic factors

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIORAL SCIENCE; CANCER SCREENING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CURRENT SMOKER; DECISION MAKING; DEMOGRAPHY; EARLY CANCER DIAGNOSIS; EX-SMOKER; FEASIBILITY STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG HEALTH CHECK; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOCIOECONOMICS; STATISTICAL ANALYSIS; BREATH ANALYSIS; DIAGNOSTIC IMAGING; LUNG TUMOR; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; PROCEDURES; SMOKING; SPIROMETRY; UNITED KINGDOM; X-RAY COMPUTED TOMOGRAPHY;

CARBON MONOXIDE;

AGED; BREATH TESTS; CARBON MONOXIDE; EARLY DETECTION OF CANCER; EX-SMOKERS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; SMOKERS; SOCIOECONOMIC FACTORS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 85083544073     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/RCCM.201905-0946OC     Document Type: Article

References (51)

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
2. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al.; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51.
3. Eastern Cancer Registration and Information Centre (ECRIC). Stage distribution of cancers diagnosed in 2009 in the East of England by cancer site and area of residence; 2009 [accessed 2019 Mar 8]. Available from: http://www.ecric.nhs.uk/docs/ECRIC_incidenceXstage_2009.pdf.
4. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al.; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
5. de Koning HJ, van der Aalst CM, Ten Haaf KE, Oudkerk M. Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. J Thorac Oncol 2018; 13:S185.
6. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol 2017;3: 1278-1281.
7. Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, et al.; National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102:1771-1779.
8. Published Erratum Appears in J Natl Cancer Inst 103:1560.
9. Yousaf-Khan U, Horeweg N, van der Aalst C, Ten Haaf K, Oudkerk M, de Koning H. Baseline characteristics and mortality outcomes of control group participants and eligible non-responders in the NELSON lung cancer screening study. J Thorac Oncol 2015;10:747-753.
10. McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362-371.
11. Pham D, Bhandari S, Oechsli M, Pinkston CM, Kloecker GH. Lung cancer screening rates: data from the lung cancer screening registry. J Clin Oncol 2018;36:6504.
12. Accelerate C, Evaluate (ACE) Programme. Proactive approaches to individuals at high risk of lung cancer; 2018 [accessed 2019 Mar 8]. Available from: https://www.cancerresearchuk.org/sites/default/files/ace_proactive_ lung_report_with_economic_evaluation_final_version_1.1a.pdf.
13. Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, et al. Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester. Thorax 2019;74:405-409.
14. Quaife SL, Vrinten C, Ruparel M, Janes SM, Beeken RJ, Waller J, et al. Smokers' interest in a lung cancer screening programme: a national survey in England. BMC Cancer 2018;18:497.
15. Quaife SL, Marlow LAV, McEwen A, Janes SM, Wardle J. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect 2017;20:563-573.
16. Smits SE, McCutchan GM, Hanson JA, Brain KE. Attitudes towards lung cancer screening in a population sample. Health Expect 2018; 21:1150-1158.
17. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their nonsmoking counterparts. Thorax 2007;62:126-130.
18. Carter-Harris L, Brandzel S, Wernli KJ, Roth JA, Buist DSM. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract 2017;34:239-244.
19. Carter-Harris L, Ceppa DP, Hanna N, Rawl SM. Lung cancer screening: what do long-term smokers know and believe? Health Expect 2017; 20:59-68.
20. Ali N, Lifford KJ, Carter B, McRonald F, Yadegarfar G, Baldwin DR, et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open 2015;5:e008254.
21. Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol 2003;22:99-105.
22. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Br J Cancer 2011;105:475-480.
23. Kerrison RS, McGregor LM, Counsell N, Marshall S, Prentice A, Isitt J, et al. Use of two self-referral reminders and a theory-based leaflet to increase the uptake of flexible sigmoidoscopy in the English bowel scope screening program: results from a randomized controlled trial in London. Ann Behav Med 2018;52:941-951.
24. Weinstein ND, Sandman PM, Blalock SJ. The precaution adoption process model. In: Health behaviour and health education. San Francisco, CA: Jossey-Bass; 2008. pp.123-147.
25. Miles A, Voorwinden S, Chapman S, Wardle J. Psychologic predictors of cancer information avoidance among older adults: the role of cancer fear and fatalism. Cancer Epidemiol Biomarkers Prev 2008; 17:1872-1879.
26. Brown S, Locker E. Defensive responses to an emotive anti-alcohol message. Psychol Health 2009;24:517-528.
27. Quaife S, Ruparel M, Dickson J, Beeken RJ, McEwen A, Baldwin D, et al. The Lung Screen Uptake Trial (LSUT): testing targeted materials to optimise informed uptake among high-risk groups. Ann Behav Med 2019;53:S21.
28. Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, et al. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients. BMC Cancer 2016;16:281.
29. Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, et al. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet 2016;387:751-759.
30. Libby G, Bray J, Champion J, Brownlee LA, Birrell J, Gorman DR, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial. J Med Screen 2011;18:24-29.
31. Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, et al. A randomised trial of the effect of postal reminders on attendance for breast screening. Br J Cancer 2016;114:171-176.
32. Hirsch EA, New ML, Brown SP, Barón AE, Malkoski SP. Patient reminders and longitudinal adherence to lung cancer screening in an academic setting. Ann Am Thorac Soc 2019;16:1329-1332.
33. Bevan R, Rubin G, Sofianopoulou E, Patnick J, Rees CJ. Implementing a national flexible sigmoidoscopy screening program: results of the English early pilot. Endoscopy 2015;47:225-231.
34. Hudson S, Brazil D, Teh W, Duffy SW, Myles JP. Effectiveness of timed and non-timed second appointments in improving uptake in breast cancer screening. J Med Screen 2016;23:160-163.
35. National Centre for Smoking Cessation and Training (NCSCT). Very brief advice training module; 2014 [accessed 2019 Mar 8]. Available from: https://www.ncsct.co.uk/publication_very-brief-advice.php.
36. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989;84:791-799.
37. Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend 2013;128:15-19.
38. Holmes-Rovner M, Kroll J, Schmitt N, Rovner DR, Breer ML, Rothert ML, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16:58-64.
39. Linder SK, Swank PR, Vernon SW, Mullen PD, Morgan RO, Volk RJ. Validity of a low literacy version of the decisional conflict scale. Patient Educ Couns 2011;85:521-524.
40. O'Connor AM. User manual - decisional conflict scale [Internet]; 2010 [accessed 2019 Mar 8]. Available from: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf.
41. Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385:1642-1652.
42. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011;40:712-718.
43. Office for National Statistics (ONS). Ethnicity and national identity in England and Wales: 2011. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/articles/ ethnicityandnationalidentityinenglandandwales/2012-12-11.
44. Shaw A, Ibrahim S, Reid F, Ussher M, Rowlands G. Patients' perspectives of the doctor-patient relationship and information giving across a range of literacy levels. Patient Educ Couns 2009;75: 114-120.
45. von Wagner C, Semmler C, Good A, Wardle J. Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns 2009;75:352-357.
46. Kahneman D. Thinking, fast and slow. London: Penguin; 2011.
47. Kobayashi LC, Waller J, von Wagner C, Wardlê J. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey. BMC Public Health 2016;16:659.
48. Fredman L, Sexton M, Cui Y, Althuis M, Wehren L, Hornbeck P, et al. Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older. Prev Med 1999;28:407-417.
49. Sutton S, Wardle J, Taylor T, McCaffery K, Williamson S, Edwards R, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 2000;7:99-104.
50. Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. Cancer screening behaviors among smokers and nonsmokers. Cancer Epidemiol 2010;34:611-617.
51. Vander Weg MW, Howren MB, Cai X. Use of routine clinical preventive services among daily smokers, non-daily smokers, former smokers, and never-smokers. Nicotine Tob Res 2012;14: 123-130.